SLCO2B1 and COVID-19: In agreement with previous reports [7,8,9], there are variants in CYP2C8, CYP2D6, CYP3A4, CYP3A5, SLCO2B1, ABCB1, ABCC2, CES1, and G6PD that could help to improve the clinical outcome of the COVID-19.